Cargando…
Protective effects of metformin against myocardial ischemia-reperfusion injury via AMPK-dependent suppression of NOX4
Numerous studies have demonstrated that metformin can reduce the incidence of myocardial infarction and improve the prognosis of patients. However, its specific mechanism has not been determined. Using a rat model of myocardial ischemia-reperfusion injury (MIRI), it was observed that metformin signi...
Autores principales: | Shi, Yan, Hou, Shu-Ai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383039/ https://www.ncbi.nlm.nih.gov/pubmed/34396450 http://dx.doi.org/10.3892/mmr.2021.12351 |
Ejemplares similares
-
Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway
por: Zhang, Jing, et al.
Publicado: (2020) -
Metformin ameliorates ferroptosis in cardiac ischemia and reperfusion by reducing NOX4 expression via promoting AMPKα
por: Wu, Zhenhua, et al.
Publicado: (2023) -
Protective approaches against myocardial ischemia reperfusion injury
por: Li, Xianchi, et al.
Publicado: (2016) -
Total saponins from Aralia taibaiensis protect against myocardial ischemia/reperfusion injury through AMPK pathway
por: YAN, JIAJIA, et al.
Publicado: (2015) -
AMPK/SIRT1 Pathway is Involved in Arctigenin-Mediated Protective Effects Against Myocardial Ischemia-Reperfusion Injury
por: Liu, Cheng-Yin, et al.
Publicado: (2021)